Casdin Capital, LLC 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-04 7:46 pm Purchase |
2025-02-28 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 80,864,315 21.600% |
7,098,241![]() (+9.62%) |
Filing |
2024-08-14 8:54 pm Purchase |
2024-08-12 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 73,766,074 19.770% |
8,468,478![]() (+12.97%) |
Filing |
2024-01-09 5:13 pm Purchase |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 65,297,596 19.710% |
27,715,250![]() (+73.75%) |
Filing |
2022-04-08 5:07 pm Purchase |
2022-04-04 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 37,582,346 32.740% |
37,582,346![]() (New Position) |
Filing |